Glenn Schulman | SVP, Corporate Communications and IR |
Peter Greenleaf | CEO and Director |
Neil Solomons | Chief Medical Officer |
Max Colao | Chief Commercial Officer |
Joe Miller | Chief Financial Officer |
Michael Martin | Chief Operating Officer |
Alethia Young | Cantor Fitzgerald |
Ed Arce | H.C. Wainwright |
Joseph Schwartz | SVB Leerink |
Justin Kim | Oppenheimer and Company |
Maury Raycroft | Jefferies |
Dae Gon Ha | BTIG |
Douglas Miehm | RBC Capital Markets |
Greetings, and welcome to the Aurinia Pharmaceuticals Second Quarter 2020 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Dr.